Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PROTI: Idebenone Withdrawal in Friedreich's Ataxia
NCT01303406Phase 3Completed
- Sponsor
- Santhera Pharmaceuticals
- Start
- Apr 2011
- Primary completion
- Jul 2012
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 3 trial of idebenone in Friedreich's ataxia (FA), sponsored by Santhera Pharmaceuticals. Started Apr 2011; status: completed.
02
Drugs
idebenone
03
Conditions
Friedreich's ataxia (FA)
Beyond the preview
Go deeper on NCT01303406.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01303406.